Group One Trading’s Acurx Pharmaceuticals ACXP Stock Holding History
Bought
Maintained
Sold
Other funds holding ACXP
Group One Trading's ACXP Position: Q3 2026 in Review
Group One Trading reduced its Acurx Pharmaceuticals (ACXP) stake by 89% in Q3 2026, selling an estimated $123 and leaving 10 shares worth $13. The position accounts for ﹤0.01% of the portfolio, ranked #7419.
Group One Trading first reported a position in ACXP in Q3 2023 and has held it in 12 quarters since. The position peaked at $33K in Q1 2024. 19 funds tracked by Wall St. Rank hold ACXP as of Q3 2026.
- Group One Trading held 10 shares of Acurx Pharmaceuticals worth $13 as of Q3 2026.
- Group One Trading sold 85 Acurx Pharmaceuticals shares in Q3 2026, an estimated $123.
- Acurx Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7419 holding.
- Group One Trading first reported a position in Acurx Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
- Group One Trading's Acurx Pharmaceuticals position peaked at $33K in Q1 2024.
- 19 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.